Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

GLYCOPYRRONIUM / FORMOTEROL FUMARATE DIHYDRATE PRESSURIZED INHALATION SUSPENSION 8.3 MCG — DIN 02473615

GLYCOPYRRONIUM (GLYCOPYRRONIUM BROMIDE) : 8.3 MCG FORMOTEROL FUMARATE DIHYDRATE : 5.8 MCG · ASTRAZENECA CANADA INC · AEROSOL, METERED DOSE · wholesale supply in Canada

Health Canada status: APPROVED

What is GLYCOPYRRONIUM / FORMOTEROL FUMARATE DIHYDRATE PRESSURIZED INHALATION SUSPENSION?

GLYCOPYRRONIUM / FORMOTEROL FUMARATE DIHYDRATE PRESSURIZED INHALATION SUSPENSION 8.3 MCG contains GLYCOPYRRONIUM (GLYCOPYRRONIUM BROMIDE) : 8.3 MCG FORMOTEROL FUMARATE DIHYDRATE : 5.8 MCG. It is listed in the Health Canada Drug Product Database under DIN 02473615, held by ASTRAZENECA CANADA INC, supplied as AEROSOL, METERED DOSE for INHALATION administration. Health Canada currently lists it as approved, status dated 16-Feb-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.

How much does Formoterol And Glycopyrronium Bromide cost around the world?

Formoterol And Glycopyrronium Bromide is listed on 10 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Belgium publishes a public; Greece publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
Belgiumpublic3434EUR███.██
United Statesacquisition122USD███.██
Slovakiacategorised final price1010EUR███.██
Hungaryproducer price (ex-factory)78HUF███.██
Icelandmax wholesale28ISK███.██
Greeceproducer price (ex-factory)77EUR███.██
Australiaex-manufacturer26AUD███.██
MoroccoPPV (public price)46MAD███.██
South Africasingle exit price22ZAR███.██
Romaniamax producer price11RON███.██

104 pack listings across 70 brand entries and 9 price bases, refreshed 08 Sep 2026. Ranges span every Formoterol And Glycopyrronium Bromide pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.

Ask Nexara for a landed Canadian price

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label8.3 MCG
Dosage formAEROSOL, METERED DOSE
RouteINHALATION

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Substance and classification

Active substanceFormoterol And Glycopyrronium Bromide
ATC codeR03AL07
AHFS class12:12.08.12 ; 12:08.08
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02473615
DIN (unpadded, as printed on some documents)2473615
Brand nameGLYCOPYRRONIUM / FORMOTEROL FUMARATE DIHYDRATE PRESSURIZED INHALATION SUSPENSION
Generic / active ingredientGLYCOPYRRONIUM (GLYCOPYRRONIUM BROMIDE) : 8.3 MCG FORMOTEROL FUMARATE DIHYDRATE : 5.8 MCG
Market authorization holderASTRAZENECA CANADA INC
Health Canada schedulePrescription
ATC codeR03AL07
ATC anatomical main groupR — Respiratory system
ATC therapeutic subgroupR03AL
Current statusAPPROVED
Status date16-Feb-2022
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

2 · Same class — other molecules in ATC R03AL

MoleculeCanadian brandsDINsMarketedSourceable
Salbutamol And Ipratropium BromideAPO-SALVENT-IPRAVENT STERULES · COMBIVENT RESPIMAT · COMBIVENT UDV · IPRAMOL · +3 more73Yes
Vilanterol, Umeclidinium Bromide And Fluticasone FuroateTRELEGY ELLIPTA22Yes
Formoterol, Glycopyrronium Bromide And BudesonideBREZTRI AEROSPHERE11Yes
Indacaterol And Glycopyrronium BromideULTIBRO BREEZHALER11Yes
Formoterol And Aclidinium BromideDUAKLIR GENUAIR11Yes
Indacaterol, Glycopyrronium Bromide And MometasoneENERZAIR BREEZHALER11Yes
Olodaterol And Tiotropium BromideINSPIOLTO RESPIMAT11Yes
Vilanterol And Umeclidinium BromideANORO ELLIPTA11Yes
Fenoterol And Ipratropium BromideDUOVENT UDV10Not in Canada
Formoterol, Glycopyrronium Bromide And BeclometasoneTRIMBOW10Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC R03A

ATC subgroupMoleculesDINsMarketed
R03AKFormoterol And Budesonide · Formoterol And Mometasone · Indacaterol And Mometasone · Salbutamol And Sodium Cromoglicate · Salmeterol And Fluticasone · +1 more2620
R03ACFenoterol · Formoterol · Indacaterol · Olodaterol · Pirbuterol · +4 more8115
R03AAEpinephrine40
R03ABIsoprenaline · Orciprenaline60

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is GLYCOPYRRONIUM / FORMOTEROL FUMARATE DIHYDRATE PRESSURIZED INHALATION SUSPENSION called?

The same molecule, Formoterol And Glycopyrronium Bromide, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
TrimbowLatinIceland
Oxis TurbuhalerLatinAustralia
BRONCOTECLatinMorocco
ForadilLatinMorocco, South Africa
ForadileLatinAustralia
Trixeo AerosphereLatinIceland
FORMANOLatinSlovakia
Formoterol EasyhalerLatinSlovakia
FORTAIRLatinMorocco

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

How can I get it?

This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.

Ask about availability of GLYCOPYRRONIUM / FORMOTEROL FUMARATE DIHYDRATE PRESSURIZED INHALATION SUSPENSION

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02473615. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.